The company has not yet released the number of common stocks to be sold or the price for the proposed offering. The offering will commence once the SEC’s review process is complete.
More Articles on Devices:
Innovating in the Minimally Invasive Spine Surgery Field: Q&A With Mazor Robotics SVP Christopher Prentice
SCOTUS Reverses Medtronic Patent Infringement Decision, Sides With Device Company
MicroPort Scientific to Build Training Facility for Orthopedic Business
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
